Scandion Oncology

Scandion is a biotechnology company. The company develops pharmaceuticals for the treatment of cancer containing drug-resistant cell clones. The leading product of the company, SCO-101, has shown to improve the effect of certain standard cancer treatments during preclinical studies. The head office of the company is located in Copenhagen.

Quotes

Board

CEO

Bo Rode Hansen

Chairperson of the Board

Peter Høngaard

Board

Annie Rasmussen
Bo Hansen
Carl Borrebäck
Christian Vinding Thomsen
Jørgen Bardenfleth
Thomas Feldthus

Articles of association

Videos

1 / 3

CompanyPresentation Presentation av Scandion Oncology A/S med CEO Bo Rode Hansen hos Nordnet Danmark (EN).

Interview Scandion Oncology’s CEO comments on ongoing rights issue

CompanyPresentation Company Presentation

*Powered by Modular Finance